6.
Chow C, Teo K, Rangarajan S, Islam S, Gupta R, Avezum A
. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013; 310(9):959-68.
DOI: 10.1001/jama.2013.184182.
View
7.
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M
. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39(33):3021-3104.
DOI: 10.1093/eurheartj/ehy339.
View
8.
Czernichow S, Zanchetti A, Turnbull F, Barzi F, Ninomiya T, Kengne A
. The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials. J Hypertens. 2010; 29(1):4-16.
DOI: 10.1097/HJH.0b013e32834000be.
View
9.
Leone A
. Does Smoking Act as a Friend or Enemy of Blood Pressure? Let Release Pandora's Box. Cardiol Res Pract. 2011; 2011:264894.
PMC: 3034987.
DOI: 10.4061/2011/264894.
View
10.
Beuret H, Hausler N, Nanchen D, Mean M, Marques-Vidal P, Vaucher J
. Comparison of Swiss and European risk algorithms for cardiovascular prevention in Switzerland. Eur J Prev Cardiol. 2021; 28(2):204–210.
DOI: 10.1177/2047487320906305.
View
11.
Mongkolsomlit S, Patumanond J, Tawichasril C, Komoltri C, Rawdaree P
. Meta-regression of risk factors for microalbuminuria in type 2 diabetes. Southeast Asian J Trop Med Public Health. 2012; 43(2):455-66.
View
12.
Visseren F, Mach F, Smulders Y, Carballo D, Koskinas K, Back M
. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021; 42(34):3227-3337.
DOI: 10.1093/eurheartj/ehab484.
View
13.
Ong K, Tso A, Lam K, Cheung B
. Gender difference in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension. Hypertension. 2008; 51(4):1142-8.
DOI: 10.1161/HYPERTENSIONAHA.107.105205.
View
14.
Nianogo R, Arah O
. Forecasting Obesity and Type 2 Diabetes Incidence and Burden: The ViLA-Obesity Simulation Model. Front Public Health. 2022; 10:818816.
PMC: 9016163.
DOI: 10.3389/fpubh.2022.818816.
View
15.
Whelton P, He J, Cutler J, Brancati F, Appel L, Follmann D
. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA. 1997; 277(20):1624-32.
DOI: 10.1001/jama.1997.03540440058033.
View
16.
Mokdad A, Ford E, Bowman B, Dietz W, Vinicor F, Bales V
. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2002; 289(1):76-9.
DOI: 10.1001/jama.289.1.76.
View
17.
de Beus E, Van Der Sande N, Bots M, Spiering W, Voskuil M, Visseren F
. Prevalence and clinical characteristics of apparent therapy-resistant hypertension in patients with cardiovascular disease: a cross-sectional cohort study in secondary care. BMJ Open. 2017; 7(9):e016692.
PMC: 5589036.
DOI: 10.1136/bmjopen-2017-016692.
View
18.
Yi S, Kansagra S
. Associations of sodium intake with obesity, body mass index, waist circumference, and weight. Am J Prev Med. 2014; 46(6):e53-5.
DOI: 10.1016/j.amepre.2014.02.005.
View
19.
Ahluwalia T, Prins B, Abdollahi M, Armstrong N, Aslibekyan S, Bain L
. Genome-wide association study of circulating interleukin 6 levels identifies novel loci. Hum Mol Genet. 2021; 30(5):393-409.
PMC: 8098112.
DOI: 10.1093/hmg/ddab023.
View
20.
Ryoo J, Kim S, Oh C, Park S, Kim E, Park S
. The incidental relationship between serum ferritin levels and hypertension. Int J Cardiol. 2015; 183:258-62.
DOI: 10.1016/j.ijcard.2014.10.152.
View